OcuSciences Company
OcuSciences is a medical diagnostic device company developing an ocular imaging technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction. The company is focused on the investigation of ocular manifestations of diabetes and therapies aimed at treating them.
Industry:
Biomarkers for Longevity
Headquarters:
Ann Arbor, Michigan, United States
Zip:
1-10
Founded Date:
2008-01-01
Employees Number:
1-10
Acquisitions Number:
1
Investors Number:
900000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Seed
Last Funding Type:
info@ocusciences.com
Register and Claim Ownership